<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00960778</url>
  </required_header>
  <id_info>
    <org_study_id>HR#18333</org_study_id>
    <nct_id>NCT00960778</nct_id>
  </id_info>
  <brief_title>Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes</brief_title>
  <acronym>BIRCWH</acronym>
  <official_title>Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the underlying neurobiology of differences between male and
      female smokers. Research suggests that women are less responsive to nicotine replacement
      therapy (NRT) than men and more responsive to the sensory and behavioral aspects of smoking.
      This study proposed that male smokers will have a greater response to NRT demonstrated by
      reduced withdrawal symptoms, craving, and less blood-oxygen-level dependent functional
      magnetic resonance imaging (BOLD FMRI) regional brain activation in response to nicotine-cues
      as compared to female smokers treated with NRT. Additionally, female smokers will have a
      greater response to denicotinized cigarettes with decreased withdrawal symptoms, craving, and
      less BOLD fMRI activation in response to nicotine-cues as compared to male smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women smokers are less responsive to nicotine replacement therapy (NRT) and more responsive
      to environmental cues associated with smoking behavior. This pilot study is designed to
      increase understanding of the neural circuitry underlying these differences. In the proposed
      study, adult male and female (10 per group) treatment-seeking nicotine-dependent individuals
      will participate in functional magnetic resonance imaging (fMRI) with the presentation of
      smoking-related cues under three conditions during a seven day period: baseline, after NRT,
      and after denicotinized cigarette facilitated-extinction. After baseline scanning, subjects
      will receive three days of 21 mg nicotine patch. Scanning procedures will be repeated on day
      3. Subjects will then receive denicotinized cigarettes for ad lib smoking on days three
      through seven. Subjects will be asked to remain abstinent throughout the study period and
      they will be assessed daily with self-report, Carbon Monoxide (CO) monitor and for nicotine
      withdrawal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post- Cue Exposure Craving Nicotine Patch</measure>
    <time_frame>Day 3</time_frame>
    <description>Participants will complete cue exposure sessions after 3 days of nicotine patch use and rate craving on a 10 item self-report questionnaire. The Within Sessions Rating scale measures craving with 0 indicating Not at All and 10 indicating Extremely.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post- Cue Exposure Craving Denicotinized Cigarettes</measure>
    <time_frame>Day 7</time_frame>
    <description>Participants will complete cue exposure sessions after 4 days of denicotinized cigarette us and rate craving on a 10 item self-report questionnaire, the Questionnaire of Smoking Urges- Brief (QSU-B). Participants rate craving on a scale on a 1-7 point Likert scale where indicates Strongly Disagree and 7 indicates Strongly Agree. Higher scores indicate higher craving. Ratings from the 10 items are summed to attain the score reported here.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Women- denicotinized cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-seeking nicotine-dependent women will participate in functional magnetic resonance imaging (fMRI) with the presentation of smoking-related cues after four days of denicotinized cigarette (less than 0.5 gram nicotine) use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Men- denicotinized cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-seeking nicotine-dependent men will participate in functional magnetic resonance imaging (fMRI) with the presentation of smoking-related cues after four days of denicotinized cigarette (less than 0.5 gram nicotine) use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women -nicotine patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-seeking nicotine-dependent women will participate in functional magnetic resonance imaging (fMRI) with the presentation of smoking-related cues under after receiving three days of a 21 mg nicotine patch.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Men- nicotine patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-seeking nicotine-dependent men will participate in functional magnetic resonance imaging (fMRI) with the presentation of smoking-related cues under after receiving three days of a 21 mg nicotine patch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nicotine patch (Nicoderm Committed Quitter (CQ), Habitrol)</intervention_name>
    <description>Nicotine patch 21 mg every 24 hours will be utilized for the three days after the first scanning session.</description>
    <arm_group_label>Men- nicotine patch</arm_group_label>
    <arm_group_label>Women -nicotine patch</arm_group_label>
    <other_name>Nicoderm Committed Quitter (CQ)</other_name>
    <other_name>Habitrol</other_name>
    <other_name>nicotine transdermal system</other_name>
    <other_name>NRT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>denicotinized cigarettes (Quest 3 cigarettes)</intervention_name>
    <description>Cigarettes that contain trace levels of nicotine (less than .05 mg per cigarette) will be utilized ad lib in the study for 4 days after the nicotine patch.</description>
    <arm_group_label>Men- denicotinized cigarette</arm_group_label>
    <arm_group_label>Women- denicotinized cigarette</arm_group_label>
    <other_name>Quest 3 cigarettes</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 21 - 60.

          2. Meet criteria for primary nicotine dependence, smoke at least 70% of days in the last
             30 days prior to assessment.

          3. Participants will have afternoon end-expired carbon monoxide levels of at least 15
             p.p.m. to confirm smoke inhalation.

          4. Moderate to high levels of nicotine dependence confirmed by Fagerstrom Test of
             Nicotine Dependence score.

          5. General good health confirmed by history &amp; physical, serum chemistries, complete blood
             count, urinalysis, and electrocardiogram.

          6. Able to read and understand questionnaires and informed consent.

          7. Right-handed.

          8. Treatment seeking.

          9. Demonstrate subjective response to cues in a laboratory cue reactivity session.

         10. Able to maintain abstinence from nicotine during the study period.

         11. Participants must have a negative rapid-screening Urine Drug Screen (UDS) and
             pregnancy test prior to both imaging sessions and placement of the patch.

         12. Female participants will use a reliable method of birth control throughout the study.

        Exclusion Criteria:

          1. Currently meets Diagnostic and Statistical Manual (DSM)-IV criteria for any other
             psychoactive substance dependence disorder except nicotine dependence.

          2. Any psychoactive substance abuse within the last 30 days as evidenced by subject
             report or urine drug screen.

          3. Use of other tobacco products.

          4. Current use of nicotine replacement therapy or other smoking cessation treatment.

          5. Meets DSM-IV criteria for current axis I disorders of major depression, panic
             disorder, obsessive compulsive disorder, post-traumatic stress syndrome, bipolar
             affective disorder, schizophrenia, or any other psychotic disorder or organic mental
             disorder. The rationale for excluding them is that symptoms from these disorders may
             affect dependent variables and complicate interpretation of the data.

          6. Current suicidal ideation with plan or homicidal ideation.

          7. Need for maintenance or acute treatment with any psychoactive medication including
             antiseizure medications.

          8. Clinically significant medical problems such as cardiovascular, renal, GI, or
             endocrine problem that would impair participation or limit ability to participate in
             scan.

          9. Sexually active females of child-bearing potential who are pregnant (by urine HCG),
             nursing, or who are not using a reliable form of birth control.

         10. Has current charges pending for a violent crime (not including Drive Under Influence
             (DUI) related offenses).

         11. Persons with ferrous metal implants or pacemaker since fMRI will be used.

         12. Persons who live with another smoker who is unwilling or unable to refrain from
             smoking in the home or presence of the participant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Hartwell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 14, 2009</study_first_submitted>
  <study_first_submitted_qc>August 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2009</study_first_posted>
  <results_first_submitted>August 28, 2018</results_first_submitted>
  <results_first_submitted_qc>September 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 23, 2018</results_first_posted>
  <last_update_submitted>September 27, 2018</last_update_submitted>
  <last_update_submitted_qc>September 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gender</keyword>
  <keyword>nicotine dependence</keyword>
  <keyword>nicotine replacement therapy</keyword>
  <keyword>extinction</keyword>
  <keyword>denicotinized cigarettes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nicotine- Dependent Women</title>
          <description>Over a period of one week, nicotine-dependent women completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
        <group group_id="P2">
          <title>Nicotine- Dependent Men</title>
          <description>Over a period of one week, nicotine-dependent men completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants were enrolled in the study and underwent baseline scanning procedures.</population>
      <group_list>
        <group group_id="B1">
          <title>Nicotine- Dependent Women</title>
          <description>Over a period of one week, nicotine-dependent women completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
        <group group_id="B2">
          <title>Nicotine- Dependent Men</title>
          <description>Over a period of one week, nicotine-dependent men completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post- Cue Exposure Craving Nicotine Patch</title>
        <description>Participants will complete cue exposure sessions after 3 days of nicotine patch use and rate craving on a 10 item self-report questionnaire. The Within Sessions Rating scale measures craving with 0 indicating Not at All and 10 indicating Extremely.</description>
        <time_frame>Day 3</time_frame>
        <population>12 women and 15 men completed the 3 days of Nictoine Replacement Therapy and completed the second scan.</population>
        <group_list>
          <group group_id="O1">
            <title>Nicotine- Dependent Women</title>
            <description>Over a period of one week, nicotine-dependent women completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
          </group>
          <group group_id="O2">
            <title>Nicotine- Dependent Men</title>
            <description>Over a period of one week, nicotine-dependent men completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
          </group>
        </group_list>
        <measure>
          <title>Post- Cue Exposure Craving Nicotine Patch</title>
          <description>Participants will complete cue exposure sessions after 3 days of nicotine patch use and rate craving on a 10 item self-report questionnaire. The Within Sessions Rating scale measures craving with 0 indicating Not at All and 10 indicating Extremely.</description>
          <population>12 women and 15 men completed the 3 days of Nictoine Replacement Therapy and completed the second scan.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.58" spread="14.82"/>
                    <measurement group_id="O2" value="25.6" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Post- Cue Exposure Craving Denicotinized Cigarettes</title>
        <description>Participants will complete cue exposure sessions after 4 days of denicotinized cigarette us and rate craving on a 10 item self-report questionnaire, the Questionnaire of Smoking Urges- Brief (QSU-B). Participants rate craving on a scale on a 1-7 point Likert scale where indicates Strongly Disagree and 7 indicates Strongly Agree. Higher scores indicate higher craving. Ratings from the 10 items are summed to attain the score reported here.</description>
        <time_frame>Day 7</time_frame>
        <population>8 women and 13 men complete the 4 days of denicotinized cigarette use and completed the third scan.</population>
        <group_list>
          <group group_id="O1">
            <title>Nicotine- Dependent Women</title>
            <description>Over a period of one week, nicotine-dependent women completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
          </group>
          <group group_id="O2">
            <title>Nicotine- Dependent Men</title>
            <description>Over a period of one week, nicotine-dependent men completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
          </group>
        </group_list>
        <measure>
          <title>Post- Cue Exposure Craving Denicotinized Cigarettes</title>
          <description>Participants will complete cue exposure sessions after 4 days of denicotinized cigarette us and rate craving on a 10 item self-report questionnaire, the Questionnaire of Smoking Urges- Brief (QSU-B). Participants rate craving on a scale on a 1-7 point Likert scale where indicates Strongly Disagree and 7 indicates Strongly Agree. Higher scores indicate higher craving. Ratings from the 10 items are summed to attain the score reported here.</description>
          <population>8 women and 13 men complete the 4 days of denicotinized cigarette use and completed the third scan.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.13" spread="14.38"/>
                    <measurement group_id="O2" value="17.85" spread="9.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Nicotine- Dependent Women</title>
          <description>Over a period of one week, nicotine-dependent women completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
        <group group_id="E2">
          <title>Nicotine- Dependent Men</title>
          <description>Over a period of one week, nicotine-dependent men completed 3 scans while being shown smoking related cues. Participants completed a baseline scan, a scan following 3 days of Nicotine Replacement Therapy (21 mg nicotine patch), and one following 4 days of denicotinized cigarette use.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Karen Hartwell</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-792-8174</phone>
      <email>hartwelk@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

